Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,660 | 143,428 | 111,966 | 130,104 | 133,035 |
| Marketable Securities | 931 | 6,381 | 18,401 | 87,875 | 37,460 |
| Receivables | 17,029 | 2,360 | 4,175 | 1,033 | N/A |
| Inventories | 8,444 | 8,272 | 1,958 | 1,811 | N/A |
| Other current assets | 424 | 293 | 729 | 1,027 | 2,137 |
| TOTAL | $109,163 | $184,586 | $163,150 | $242,830 | $195,722 |
| Non-Current Assets | |||||
| PPE Net | 135,270 | 137,094 | 139,285 | 141,956 | 143,517 |
| Intangibles | 15,443 | 0 | 16,479 | 16,058 | 16,572 |
| Other Non-Current Assets | 43,883 | 61,253 | 45,656 | 43,481 | 44,868 |
| TOTAL | $194,596 | $198,347 | $201,420 | $201,495 | $204,957 |
| Total Assets | $303,759 | $382,933 | $364,570 | $444,325 | $400,679 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,856 | 6,898 | 10,331 | 20,517 | 14,965 |
| Accrued Expenses | 27,889 | 40,580 | 43,596 | 35,344 | 32,712 |
| TOTAL | $49,205 | $54,944 | $60,960 | $62,110 | $53,759 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 111,143 | 108,811 | 106,637 |
| Other Non-Current Liabilities | 845,056 | 816,135 | 936,652 | 970,802 | 931,287 |
| TOTAL | $845,036 | $816,118 | $1,047,772 | $1,079,593 | $1,037,903 |
| Total Liabilities | $894,241 | $871,062 | $1,108,732 | $1,141,703 | $1,091,662 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 882,620 | 853,442 | 696,831 | 696,533 | 691,568 |
| Common Shares | 85 | 85 | 70 | 69 | 68 |
| Retained earnings | -3,504,894 | -3,375,248 | -3,316,086 | -3,230,357 | -3,095,793 |
| Other shareholders' equity | 20,905 | 2,167 | 1,089 | 1,001 | 1,022 |
| TOTAL | $-590,482 | $-488,129 | $-744,162 | $-697,378 | $-690,983 |
| Total Liabilities And Equity | $303,759 | $382,933 | $364,570 | $444,325 | $400,679 |